<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=335994581855197&amp;ev=PageView&amp;noscript=1">
Email 2 (1)

The Economic Impacts of Schedule III on Federal Research and the Cannabis Industry

Originally Aired: September 13th at 12pm CST

On August 30th, the U.S. Department of Health and Human Services issued a recommendation that cannabis be rescheduled to Schedule III under the Controlled Substances Act.

In this on-demand Rootwurks webinar, you can hear economist, business analyst, and general cannabis policy wonk Andrew Livingston of the cannabis law firm Vicente LLP break down why this development sent shock waves through the cannabis industry and what it would mean for cannabis research and the industry as a whole.  

About this Webinar

Federal legalization may still be a long way off, but the U.S. Department of Health and Human Sevices’ call for the rescheduling of cananbis to Schedule III signals a new era for the industry. 

If approved by the Drug Enforcement Adminstration, the move to Schedule III is a major sign that the federal government is changing its approach to cannabis.

And for a cannabis industry that has been reeling in recent years, the move should provide much-needed assistance when it comes to issues ranging from taxation to the quest for funding. 

In this on-demand Rootwurks webinar, you can hear Vicente LLP’s Director of Economics and Research, Andrew Livingston, discuss what rescheduling means for controlled substances like cannabis, and what the potential economic ramifications will be for cannabis research and the industry as a whole.

Circle 1 (9)

Who Can Benefit?

The reclassification of cannabis would have a major impact on the industry as a whole and would also have ramifications for all types of cannabis consumers. 

This webinar will benefit viewers who would like to learn more about what Schedule III entails and how reclassification would affect the cannabis industry. 

Circle 2 (9)

Viewers will gain expert insight on:

  • What it means to reschedule cannabis to Schedule III
  • How Schedule III is different from Schedule I and II 
  • How rescheduling would affect 280E
  • How cannabis markets and investors are reacting to the news 
  • What rescheduling will mean for cannabis research and development 
  • What it will mean for cannabis enforcement
  • If rescheduling will make it easier for cannabis companies to secure funding
  • If rescheduling could open the door to federal legalization
  • What WON’T rescheduling mean for cannabis?
  • and more!

Meet Your Speaker


Andrew Livingston - Director of Economics & Research | Vicente LLP

Andrew Livingston is based in Vicente LLP’s Denver office, where he serves as the firm's director of economics and research. In this role, he assists clients with developing and expanding their enterprises across cannabis markets nationally and internationally.

Andrew has spent his entire career studying cannabis markets, first working alongside the VS team in 2012 on the historic campaign to pass Amendment 64, which legalized marijuana for adults in Colorado.

Our Webinar Partner

This event would not be possible without our partner's insight and years of experience in the cannabis industry.

Full Color_Logo (1)
Screen Shot 2022-01-21 at 11.40.37 AM

Hosted by Rootwurks

Rootwurks is an e-learning and risk management company built by a team of experts with more than 100 years of combined knowledge and experience in compliance and safety training. After many years spent in senior roles at one of the largest food safety training companies in the country, our founders launched Rootwurks and built the Rootwurks Learning Experience Platform (LXP) to help companies navigate the complex and crucial safety and compliance demands in industries as varied and challenging as cannabis and food manufacturing.